Cognitive Ability, General Clinical Trial
Official title:
Neurodevelopment at 5.5 Years of Age in Children Who Received Infant Formula With Enriched Protein Fractions
NCT number | NCT04442477 |
Other study ID # | 6027-2 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 15, 2020 |
Est. completion date | May 27, 2021 |
Verified date | December 2021 |
Source | Mead Johnson Nutrition |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a follow-up study of a multi-center, double-blind, randomized, controlled, parallel-designed, prospective trial and is intended to evaluate neurodevelopment at 5.5 years of age and health outcomes through 5.5 years of age in participants who received one of two staged study formulas through one year of age.
Status | Completed |
Enrollment | 116 |
Est. completion date | May 27, 2021 |
Est. primary completion date | May 27, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 64 Months to 68 Months |
Eligibility | Inclusion Criteria: - Participant who previously consumed study formula through one year of age in MJN Project 6027 - 5.5 years of age (i.e. when child turns 5 years and 6 months old ± 2 months) at Visit 1 - Signed informed consent obtained for child's participation in the study Exclusion Criteria: - No exclusion criteria |
Country | Name | City | State |
---|---|---|---|
China | Fuyang Fifth People's Hospital | Anhui |
Lead Sponsor | Collaborator |
---|---|
Mead Johnson Nutrition |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Wechsler Preschool & Primary Scale of Intelligence™ (Fourth Edition; WPPSI™-IV) | At 5.5 years of age | ||
Secondary | Dimensional Change Card Sort (DCCS) | At 5.5 years of age | ||
Secondary | Stroop Task | At 5.5 years of age | ||
Secondary | Functional Near Infrared Spectroscopy (fNIRS) | At 5.5 years of age | ||
Secondary | Child Behavior Checklist (CBCL) | At 5.5 years of age | ||
Secondary | Body weight | At 5.5 years of age | ||
Secondary | Body height | At 5.5 year of age | ||
Secondary | Health history outcomes | At 5.5 years of age |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT00747396 -
The Bucharest Early Intervention Project
|
N/A | |
Completed |
NCT01407770 -
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
|
||
Completed |
NCT02394899 -
Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease
|
N/A | |
Completed |
NCT02274883 -
The Effect of Feeding Infant Formula With Enriched Protein Fractions
|
N/A | |
Enrolling by invitation |
NCT02066571 -
Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease
|
Phase 2 | |
Completed |
NCT02780739 -
INSIGHT, A Comprehensive, Multidisciplinary Brain Training System
|
N/A | |
Completed |
NCT01359215 -
Childhood Anesthesia and Cognitive Function
|
N/A | |
Completed |
NCT02461693 -
Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT
|
N/A | |
Completed |
NCT01868165 -
Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)
|
||
Completed |
NCT02630667 -
The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition
|
N/A | |
Completed |
NCT01375348 -
Relationship Between Cognitive Function and Pain
|
Phase 3 | |
Completed |
NCT02853279 -
Physical Activity and Intermittent Exercise Training for Cardiovascular and Cognitive Gain in Obese Women
|
N/A | |
Completed |
NCT00894205 -
Neuropsychological Effects of Strengthening Exercise for Older Adults
|
Phase 2 | |
Completed |
NCT01167400 -
Cybercycling for Cognitive Health
|
N/A | |
Completed |
NCT03137836 -
Classroom Standing Desks for Reducing Sitting Time in Children
|
N/A | |
Completed |
NCT02136368 -
Body and Brain Exercise for Older Adults With Memory Complaints
|
N/A | |
Completed |
NCT00841321 -
Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
|
Phase 2 | |
Active, not recruiting |
NCT01504633 -
Nutrigenomics, PUFA, Iron and Cognition Amongst Under-two-year-old Indonesian Children
|
N/A | |
Completed |
NCT02726906 -
Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study
|
N/A | |
Not yet recruiting |
NCT02123355 -
The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery
|
Phase 4 |